Program to prevent peer aggression and dating violence in preteens receiving mental health services
Cross-Cutting Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
This study is testing a new program to see if it can help preteens in mental health treatment reduce bullying and dating violence by teaching them social skills and how to manage their emotions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 88 (estimated) |
| Ages | 11 Years to 13 Years |
| Sex | All |
| Sponsor | Rhode Island Hospital Academic / other |
| Locations | 1 site (Providence, Rhode Island) |
| Trial ID | NCT06769282 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the SPARE program, which aims to reduce peer aggression and prevent teen dating violence among preteens receiving intensive mental health services. The intervention includes social skills training, problem-solving, emotion regulation, and psycho-education on trauma, delivered through group therapy sessions. Participants will be compared to a control group receiving standard treatment to assess the effectiveness of SPARE in improving mental health outcomes and reducing aggressive behaviors over time.
Who should consider this trial
Good fit: Ideal candidates for this study are preteens aged 11-13 years who are enrolled in a partial hospitalization program and require intensive mental health services.
Not a fit: Patients who are not enrolled in intensive mental health services or are outside the age range of 11-13 years may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce aggression and dating violence among vulnerable preteens, leading to improved mental health and social outcomes.
How similar studies have performed: While similar interventions targeting aggression and dating violence have shown promise, the specific approach of SPARE is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) aged 11-13 years * (2) enrolled in CP, * (3) ability to write and speak in English * (4) parent/guardian consent. Exclusion Criteria: * None
Where this trial is running
Providence, Rhode Island
- Rhode Island Hospital — Providence, Rhode Island, United States (Recruiting)
Study contacts
- Principal investigator: Elizabeth C Tampke, PhD — Rhode Island Hospital
- Study coordinator: Elizabeth C Tampke, Ph.D.
- Email: elizabeth_tampke@brown.edu
- Phone: (401) 793-8351
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.